Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg + Dolutegravir 50 mg + abacavir 600 mg/lamivudine 300 mg
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Healthy Subjects
Conditions
Healthy Subjects, Infection, Human Immunodeficiency Virus
Trial Timeline
Jun 1, 2011 → Jul 1, 2011
NCT ID
NCT01366547About Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg + Dolutegravir 50 mg + abacavir 600 mg/lamivudine 300 mg
Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg + Dolutegravir 50 mg + abacavir 600 mg/lamivudine 300 mg is a phase 1 stage product being developed by Shionogi for Healthy Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT01366547. Target conditions include Healthy Subjects, Infection, Human Immunodeficiency Virus.
What happened to similar drugs?
20 of 20 similar drugs in Healthy Subjects were approved
Approved (20) Terminated (1) Active (0)
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01622790 | Phase 1 | Completed |
| NCT01366547 | Phase 1 | Completed |
Competing Products
20 competing products in Healthy Subjects
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Use of Wearable Digital Sensors After mRNA Vaccination in Adults | Moderna | Preclinical | 0 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| mRNA-6231 | Moderna | Phase 1 | 0 |
| Letrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Isotretinoin | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Fexofenadine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sertraline | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Nizatidine + Axid | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Anastrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-1273.712 | Moderna | Approved | 0 |
| Risperidone | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Metformin + Glucophage | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| Divalproex Sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sirolimus | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Glimepiride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Ziprasidone Hydrochloride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Naproxen sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |